189 related articles for article (PubMed ID: 16814097)
1. Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression".
Lee HG; Perry G; Zhu X; Nunomura A; Smith MA
Free Radic Biol Med; 2006 Jul; 41(2):188-9. PubMed ID: 16814097
[No Abstract] [Full Text] [Related]
2. The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression.
Tamagno E; Bardini P; Guglielmotto M; Danni O; Tabaton M
Free Radic Biol Med; 2006 Jul; 41(2):202-12. PubMed ID: 16814100
[TBL] [Abstract][Full Text] [Related]
3. Protein-protein interactions in the assembly and subcellular trafficking of the BACE (beta-site amyloid precursor protein-cleaving enzyme) complex of Alzheimer's disease.
Parsons RB; Austen BM
Biochem Soc Trans; 2007 Nov; 35(Pt 5):974-9. PubMed ID: 17956258
[TBL] [Abstract][Full Text] [Related]
4. Promising anti-Alzheimer's dimer bis(7)-tacrine reduces beta-amyloid generation by directly inhibiting BACE-1 activity.
Fu H; Li W; Luo J; Lee NT; Li M; Tsim KW; Pang Y; Youdim MB; Han Y
Biochem Biophys Res Commun; 2008 Feb; 366(3):631-6. PubMed ID: 18039469
[TBL] [Abstract][Full Text] [Related]
5. The increased activity of BACE1 correlates with oxidative stress in Alzheimer's disease.
Borghi R; Patriarca S; Traverso N; Piccini A; Storace D; Garuti A; Gabriella Cirmena ; Patrizio Odetti ; Massimo Tabaton
Neurobiol Aging; 2007 Jul; 28(7):1009-14. PubMed ID: 16769154
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the lipidation of beta-secretase by statins.
Parsons RB; Farrant JK; Price GC; Subramaniam D; Austen BM
Biochem Soc Trans; 2007 Jun; 35(Pt 3):577-82. PubMed ID: 17511656
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation.
Shimmyo Y; Kihara T; Akaike A; Niidome T; Sugimoto H
Neuroreport; 2008 Aug; 19(13):1329-33. PubMed ID: 18695518
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
9. A novel beta-site amyloid precursor protein cleaving enzyme (BACE) isoform regulated by nonsense-mediated mRNA decay and proteasome-dependent degradation.
Tanahashi H; Tabira T
Neurosci Lett; 2007 Nov; 428(2-3):103-8. PubMed ID: 17961921
[TBL] [Abstract][Full Text] [Related]
10. Progress toward the discovery and development of efficacious BACE inhibitors.
Durham TB; Shepherd TA
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):776-91. PubMed ID: 17117686
[TBL] [Abstract][Full Text] [Related]
11. Caspase-3 cleavage of GGA3 stabilizes BACE: implications for Alzheimer's disease.
Vassar R
Neuron; 2007 Jun; 54(5):671-3. PubMed ID: 17553417
[TBL] [Abstract][Full Text] [Related]
12. Translational control of BACE1 may go awry in Alzheimer's disease.
Wong PC
Neuron; 2008 Dec; 60(6):941-3. PubMed ID: 19109900
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation.
Wozniak MA; Itzhaki RF; Shipley SJ; Dobson CB
Neurosci Lett; 2007 Dec; 429(2-3):95-100. PubMed ID: 17980964
[TBL] [Abstract][Full Text] [Related]
15. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta precursor protein processing in neurodegeneration.
Wilquet V; De Strooper B
Curr Opin Neurobiol; 2004 Oct; 14(5):582-8. PubMed ID: 15464891
[TBL] [Abstract][Full Text] [Related]
18. Morphine via nitric oxide modulates beta-amyloid metabolism: a novel protective mechanism for Alzheimer's disease.
Pak T; Cadet P; Mantione KJ; Stefano GB
Med Sci Monit; 2005 Oct; 11(10):BR357-66. PubMed ID: 16192893
[TBL] [Abstract][Full Text] [Related]
19. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
[TBL] [Abstract][Full Text] [Related]
20. [Oxidative stress, beta-amyloide peptide and Alzheimer's disease].
Manzano-León N; Mas-Oliva J
Gac Med Mex; 2006; 142(3):229-38. PubMed ID: 16875352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]